Daniel H Solomon

Rheumatologist & epidemiologist at Brigham and Women's Hospital, Section of Clinical Sciences, and Professor of Medicine at Harvard Medical School.

[Steven Echard, CAE @StevenEchard]

During this past year- For the First time Ever….The leaders of all 3 @ACRheum organizations are women. @AWIRGROUP #WomenRheum #ACR24
#ACR24

[UNMC Rheum @UNMC_Rheum]

Big congratulations to Dr. Mikuls on this well deserved award!

[ACR_Journals @ACR_Journals]

2024 editor's picks from A&R being presented at #ACR24 Sunday, Nov 17, 10:30AM~
Risk of Lung Cancer in RA and RA-ILD
https://t.co/zv1hlVKkDx
Genetic and Clinical Risk Factors for Classifying Uveitis Risk in JIA
https://t.co/OJgjfYIe8V

[ACR_Journals @ACR_Journals]

Meet the Editors of A&R, AC&R, and ACROR at #ACR24
Monday, Nov 18, 8AM in the Networking Lounge
Ask about publishing rheum research or just drop in and say 'Hi'!

[American College of Rheumatology @ACRheum]

Congratulations to Diane Lacaille, MD, FRCPC, recipient of the 2024 Excellence in Investigative Mentoring Award! @DianeLacaille @Arthritis_ARC @UBC #ACR24

[American College of Rheumatology @ACRheum]

Congratulations to Ted Mikuls, MD, MSPH, recipient of the 2024 Excellence in Investigative Mentoring Award! @MikulsTed @unmc #ACR24

[American College of Rheumatology @ACRheum]

Congratulations to Philip Seo, MD, MHS, recipient of the 2024 Distinguished Service Award! @philseo #ACR24

[ACR_Journals @ACR_Journals]

The vicious cycle of macrophage activation syndrome, and therapeutic strategies for blocking the cycle

[ACR_Journals @ACR_Journals]

Myeloid-derived suppressor cells (MDSCs) contribute to SLE pathogenesis. This study investigated whether FoxO1 deficiency in monocyte MDSCs enhances aberrant B cell function in lupus. Results suggest therapeutic potential of targeting ALKBH5/FoxO1/Met in monocyte MDSCs

In A&R
https://t.co/bhpA5jMfd8

[CARRA @carrainc]

👋🏽 We're heading to Washington, DC next week for @ACRheum's #ACR24! We hope to see many of you there!

[ACR_Journals @ACR_Journals]

New installment in the Arthritis & Rheumatology Immunology for the Rheumatologist review series:
Macrophage activation syndrome
https://t.co/dfysIrpIEJ

[Jeffrey Sparks MD MMSc @jeffsparks]

Looking forward to presenting at #ACR24!
@ACRheum @BrighamWomens @BrighamResearch @MassGenBrigham

[ACR_Journals @ACR_Journals]

Trends in DMARD use for children with juvenile idiopathic arthritis from US commercial claims data 2000-2022:
•csDMARD use declined 89.5% to 43.2%
•bDMARD use increased 10.5% to 50%
•adalimumab most commonly initiated b/tsDMARD at 20.5% in 2022
•after 1st csDMARD, adalimumab most common b/tsDMARD at 77.8%
•TNFi use declined (etanercept peaked at 28.3% in 2006 and declined to 4.2%)

[ACR_Journals @ACR_Journals]

Using an int'l, multicenter database, this study identified clinical and serologic variables associated with anti-synthetase syndrome to aid in development of classification criteria

In A&R
https://t.co/r5wFzqeQqY

[ACR_Journals @ACR_Journals]

In Arthritis & Rheumatology
https://t.co/LedptiOmYD

[American College of Rheumatology @ACRheum]

NEW EPISODE! What do antinuclear antibodies & immunologically active DNA have to do with the pathogenesis of #SLE? Let’s dive in with David S. Pisetsky, MD, PhD, HERE → https://t.co/UBhmceM0j9 @ACR_Journals

[American College of Rheumatology @ACRheum]

Congratulations to Daniel Solomon, MD, PhD, recipient of the 2024 Distinguished Clinical Investigator Award! @DanielHSolomon @BrighamWomens @harvardmed #ACR24

[Rheumatology Research Foundation @RheumResearch]

Joel Kremer, MD & Sara Kremer commit $1M to support early & mid-career rheumatology researchers! Their gift drives crucial research & inspires others to make a lasting impact. #rheumresearch Read the full press release at https://t.co/7khMkQBUUy

[Rohit Aggarwal @docrota]

Hot off the press: Most comprehensive analysis on Anti-Synthetase Syndrome (ASSD) is out. Paper by Akira Yoshida, Sara Kashani, Giovanni of CLASS in A&R. Stay tuned for 1st ever Classification Criteria of Anti-ASSD presented at #ACR2024 by Giovanni et al. https://t.co/Rm5RlhUdij